# Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction

Study · id `cardio:ct-nct03155022` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03155022](<https://clinicaltrials.gov/study/NCT03155022>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03155022

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 750 participants.

## Technical summary

Registry record NCT03155022. Randomized; single masking; primary purpose treatment. Start 2018-04-12 (actual); primary completion 2023-10-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 750 participants (enrolled count; ClinicalTrials.gov record NCT03155022, source copy `cardio:ctgov-nct03155022-2026-05-08`, retrieved 2026-10-26)
- Started: 2018-04-12 (actual) (ClinicalTrials.gov record NCT03155022, source copy `cardio:ctgov-nct03155022-2026-05-08`, retrieved 2026-10-26)
- Primary completion: 2023-10-03 (actual) (ClinicalTrials.gov record NCT03155022, source copy `cardio:ctgov-nct03155022-2026-05-08`, retrieved 2026-10-26)
- Completion: 2023-10-03 (actual) (ClinicalTrials.gov record NCT03155022, source copy `cardio:ctgov-nct03155022-2026-05-08`, retrieved 2026-10-26)
- Countries: Belgium; France (ClinicalTrials.gov record NCT03155022, source copy `cardio:ctgov-nct03155022-2026-05-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03155022-2026-05-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction
- Acronym: CARIOCA
- Condition: Myocardial Infarction, Acute
- Intervention (Device): Remote ischemic conditioning and intracoronary ischemic conditioning
- Intervention (Device): Patients with no remote ischemic conditioning and no intracoronary ischemic conditioning
- Lead sponsor: Hospices Civils de Lyon
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Hospices Civils de Lyon (`cardio:org-hospices-civils-de-lyon`)

## Provenance

Content hash: d8b93e8ed61c77d5545d5290e403a8a17784feaaf6299486c42dbbdd8818255d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
